| Sandoz Pharmaceuticals AG - Naropin 2 mg/ml, Injektions-/Infusionslösung |
| 54015 | | 01 | | Naropin 2 mg/ml | | Injektions-/Infusionslösung | | N01BB09 | | Ropivacaine | | 27.02.1997 | | |
|
| Composition |
| ropivacaini hydrochloridum 2 mg corresp. ropivacainum 1.8 mg, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium max. 3.7 mg. |
| Packungsbestandteile |
| Infusion solution | | | | | | Active Agent | Dose |
|---|
| Ropivacaine Hydrochloride | 2 mg/ml correspond Ropivacaine 1.8 mg/ml |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Sodium Chloride | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 5 x 10 ml | PR | PR | B | | No | | 002 | 5 x 20 ml | PR | PR | B | | No | | 119 | 5 1 Infusion Bag(s) à 200 ml | PR | PR | B | | Yes |
|
